![Nautilus Biotechnology, Inc. logo](/logos/NAUT.webp)
Nautilus Biotechnology, Inc.
NASDAQ:NAUT
Overview | Financials
Company Name | Nautilus Biotechnology, Inc. |
Symbol | NAUT |
Currency | USD |
Price | 2.55 |
Market Cap | 319,798,050 |
Dividend Yield | 0% |
52-week-range | 2.19 - 4 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Sujal M. Patel |
Website | https://www.nautilus.bio |
An error occurred while fetching data.
About Nautilus Biotechnology, Inc.
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was founded in 2016 and is
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD